Search results
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024 By Investing.com
Investing.com· 5 days agoAquestive Therapeutics (NASDAQ: NASDAQ:AQST) has shared an optimistic update during its...
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Trans
Guru Focus· 6 days agoAmphastar Pharmaceuticals Inc reported a significant year-over-year increase in net revenue, rising 23% to $171.8 million. The company successfully launched Rexulti, an intranasal naloxone product ...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 4 days agoHeparin to thin blood. Epinephrine injection for severe allergies. They’re among 128 drugs listed on...
Frank Maggio, RN, receives Alice Hyde DAISY Award
Plattsburgh Press-Republican· 5 hours agoFrank Maggio, RN, was honored as UVM Health Network – Alice Hyde Medical Center’s latest recipient of the DAISY Award for Extraordinary Nurses, after...
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...
GuruFocus.com via Yahoo Finance· 1 day agoThe San Diego-based biopharmaceutical company, known for its development of neffy (epinephrine nasal spray), reported a net loss of $10.3 million, aligning closely with analyst ...
More people need transplants than there are organ donors. Pigs might be a solution
CNN via Yahoo News· 5 days agoThe need for transplant organs is immense and growing. Some scientists think animal organs might be...
Safar Partners Leads Pirouette’s Investment Round with $5M+ Raised, Extending Opportunity for Public...
VentureBeat· 7 days agoLed by a team of rocket scientists from MIT, Harvard Medical School, Harvard Business School,...
Orexo Q1 2024 Interim Report
NBC 17 Raleigh· 6 days ago...and Vorvida® were reimbursed within the US Veterans Affairs Federal Supply Schedule as of January 1, 2024Data from the clinical phase 1 study and stability data for OX640, a nasal epinephrine powder product, were presented at the American Academy of Allergy, Asthma & Immuniology Annual Meeting in...
Sarina Tanimoto Sells 100,000 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock
ETF DAILY NEWS· 2 days agoARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of ARS Pharmaceuticals stock in a transaction on Tuesday, May 7th. The shares were sold ...
The Worsening Prescription Drug Shortage and How to Cope With It - NerdWallet
Nerdwallet· 4 days agoPatients and their health care providers are also being hit with much more consequential shortages,...
